null

Amatuximab (Anti-Mesothelin) Biosimilar Antibody

SKU:
HDBS0021
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
MSLN
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-Mesothelin amatuximab biosimilar mAb HDBS0021
  • Anti-Mesothelin amatuximab biosimilar mAb HDBS0021
  • Anti-Mesothelin amatuximab biosimilar mAb HDBS0021
$448
Frequently bought together:

Description

system_update_altDatasheet

Amatuximab (Anti-Mesothelin) Biosimilar Antibody (HDBS0021)

The Anti-Mesothelin (Amatuximab) Biosimilar Monoclonal Antibody (HDBS0021) is a cutting-edge research tool for studying mesothelin, a cell surface glycoprotein overexpressed in various cancers, including mesothelioma and ovarian cancer. This monoclonal antibody, which is a biosimilar to Amatuximab, offers high specificity and sensitivity for detecting mesothelin in human samples, making it an essential tool for cancer research and diagnostic applications.Mesothelin is a promising target for cancer therapy and diagnosis due to its selective expression in cancer cells and limited expression in normal tissues. The Anti-Mesothelin (Amatuximab) Biosimilar Monoclonal Antibody (HDBS0021) binds specifically to mesothelin, enabling precise detection and analysis of this protein in tumor samples.

Its high affinity and specificity make it suitable for various experimental techniques, including immunohistochemistry, Western blotting, and flow cytometry.By facilitating the study of mesothelin, the Anti-Mesothelin (Amatuximab) Biosimilar Monoclonal Antibody (HDBS0021) contributes to advancing our understanding of cancer biology and potentially opening up new avenues for targeted cancer therapies. Researchers and clinicians can rely on this high-quality antibody to support their investigations into mesothelin's role in tumorigenesis, metastasis, and therapeutic resistance, ultimately leading to